CARY reported strong Q2 performance with an 81% sales growth, including 7% organic growth adjusted for working days, and a 62% increase in adjusted EBITDA.
The company continues its acquisition strategy, completing major deals like Charles Pugh in the UK and Express Glass in Portugal, though initial integration has caused margin dilution.
Adjusted EBITA margin for Q2 was 16.1%, with strong performance in the Nordics (26.7% margin) but challenges in the UK due to capacity issues and slower integration progress.
Cost-saving initiatives in Norway and the UK are expected to yield SEK 5-10 million in 2022 and SEK 25 million annually from 2023 onwards, with no impact yet reflected in Q2 results.
The leverage ratio increased to 4.3x due to acquisitions, but strong cash flow and price increases (5-10% in Nordics) are expected to support gradual deleveraging.